|
시장보고서
상품코드
1935206
칸디다증 시장 : 약제 클래스별, 유형별, 투여 경로별, 유통경로별, 지역별Candidiasis Market, By Drug Class, By Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
칸디다증 시장은 2026년에 13억 720만 달러로 추정되며, 2033년까지 17억 9,070만 달러에 이를 것으로 예측됩니다. 또한, 2026-2033년 CAGR 4.6%를 나타낼 전망입니다.
| 보고서 커버 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 13억 720만 달러 |
| 과거 데이터 대상 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 4.60% | 2033년 시점 예측 : | 17억 9,070만 달러 |
칸디다증은 경구약, 주사, 연고 등 다양한 치료법으로 치료할 수 있습니다. 일반적으로 시중에서 판매되는 약이나 특정 처방에 따라 항진균제를 사용하여 치료합니다. 칸디다증에 대한 소비자의 인식이 높아지고 치료 옵션이 증가함에 따라 칸디다증 시장의 성장을 가속하는 주요 요인으로 작용하고 있습니다.
시장 역학
칸디다증 세계 시장은 칸디다 알비칸스(Candida albicans)에 의한 침습성 진균 감염에 대한 광범위한 항진균 활성을 나타내는 신규 약물의 개발 연구 개발이 진행됨에 따라 큰 폭의 성장이 예상됩니다. 예를 들어, 2018년 10월 미국 미생물학회 연구진은 알렉시딘이염산염이라는 화합물을 확인했습니다. 이 화합물은 다양한 곰팡이 병원균에 대해 최고의 항진균 활성 및 항바이오필름 활성을 나타내어 범용 항진균제로서의 사용 가능성이 높은 것으로 알려져 있습니다.
그러나 시중에서 쉽게 구할 수 있는 일반의약품 등 대체 치료제가 쉽게 구할 수 있는 상황은 시장 성장에 걸림돌이 될 것으로 예측됩니다.
본 조사의 주요 특징
- 이 보고서는 2025년을 기준 연도로 하여 세계 칸디다증 시장에 대한 상세한 분석을 제공하며, 예측 기간(2026-2033년) 시장 규모와 연평균 성장률(CAGR)을 제시합니다.
- 또한, 다양한 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 시장 성장 촉진요인, 저해요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들이 채택하고 있는 경쟁 전략에 대한 중요한 정보도 제공합니다.
- 이 보고서는 기업 개요, 재무 성과, 제품 포트폴리오, 시장 점유율, 유통 전략, 주요 개발, 전략, 미래 계획과 같은 매개 변수를 기반으로 세계 칸디다증 시장의 주요 업체를 프로파일링합니다.
- 이 보고서는 각 기업의 마케팅 담당자와 경영진이 향후 제품 출시, 기술 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내리는 데 도움이 될 것입니다.
- 이 세계 칸디다증 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 칸디다증 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 범위
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 칸디다증 치료제 시장 : 약제 클래스별, 2026년-2033년
제5장 세계의 칸디다증 치료제 시장 : 유형별, 2026년-2033년
제6장 세계의 칸디다증 시장 : 투여 경로별, 2026년-2033년
제7장 세계의 칸디다증 시장 : 유통경로별, 2026년-2033년
제8장 세계의 칸디다증 치료제 시장 : 지역별, 2026년-2033년
제9장 경쟁 구도
제10장 섹션
LSH 26.03.09Candidiasis Market is estimated to be valued at USD 1,307.2 Mn in 2026 and is expected to reach USD 1,790.7 Mn by 2033, growing at a compound annual growth rate (CAGR) of 4.6% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,307.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.60% | 2033 Value Projection: | USD 1,790.7 Mn |
Candidiasis is treated using various treatment options such as oral medication, injection, and ointments. The condition is usually treated using over-the-counter antifungal medicines and also specific prescription-based antifungal medicines. Increasing consumer awareness about candidiasis and growing number of treatment options are major factors that are fueling growth of the candidiasis market.
Market Dynamics
The global candidiasis market is expected to witness significant growth, owing to increasing research for development of novel medications showcasing broad-spectrum antifungal activity against invasive fungal infections caused due to Candida albicans. For instance, in October 2018, researchers at the American Society for Microbiology identified a compound alexidine dihydrochloride, which has the highest antifungal and anti-biofilm activity against a diverse range of fungal pathogens, thus having a greater potential for use as a pan-antifungal drug.
However, easy access to alternative treatment methods such as over-the-counter treatments and others are expected to hinder the market growth.
Key features of the study
- This report provides in-depth analysis of the global candidiasis market and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2026-2033), considering 2025 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global candidiasis market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
- Key companies covered as a part of this study include, Basilea Pharmaceutica Ltd., Astellas Pharma Inc., Grupo Ferrer Internacional, S.A., Pacgen Life Science Corporation, NovaDigm Therapeutics, Inc., Cidara Therapeutics, Inc., Amplyx Pharmaceuticals Inc., and Pfizer, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global candidiasis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global candidiasis market
Market Segmentation
- By Drug Class
- Azoles
- Echinocandins
- Polyenes
- Flucytosine
- By Type
- Candida infections of the mouth, throat, and esophagus
- Vaginal candidiasis
- Invasive/Systemic candidiasis
- By Route of Administration
- Oral
- Parenteral
- Topical
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- Basilea Pharmaceutica Ltd.
- Astellas Pharma Inc.
- Grupo Ferrer Internacional, S.A.
- Pacgen Life Science Corporation
- NovaDigm Therapeutics, Inc.
- Cidara Therapeutics, Inc.
- Amplyx Pharmaceuticals Inc.
- Pfizer, Inc
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Class
- Market Snippet, By Type
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Adherence and Switch (U.S.)
- Market Trends
- Pipeline Analysis
- Key Developments
- Regulatory Scenario
- Reimbursement Scenario
- Merger and Acquisition Scenario
- PEST Analysis
- Epidemiology
4. Global Candidiasis Market, By Drug Class, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Azoles
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Echinocandins
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Polyenes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Flucytosine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
5. Global Candidiasis Market, By Type, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Candida infections of the mouth, throat, and esophagus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Vaginal candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Invasive/Systemic candidiasis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
6. Global Candidiasis Market, By Route of Administration, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
7. Global Candidiasis Market, By Distribution Channel, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
8. Global Candidiasis Market, By Region, 2026 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- North America
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Drug Class, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Route of Administration, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country/Region, 2026 - 2033, (USD Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Basilea Pharmaceutica Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Astellas Pharma Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Grupo Ferrer Internacional, S.A.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pacgen Life Science Corporation
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- NovaDigm Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cidara Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Amplyx Pharmaceuticals Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Pfizer, Inc.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
- Basilea Pharmaceutica Ltd.
10. Section
- References
- Research Methodology
- About Us and Sales Contact
샘플 요청 목록